Molecular Dynamics investigation of the interaction between ACE2 and the spike glycoprotein of SARS-CoV-2, in comparison with its predecessors from bat and pangolin

  • Funded by Partnership for Advanced Computng in Europe (PRACE)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    Partnership for Advanced Computng in Europe (PRACE)
  • Principal Investigator

    Giovanni Chillemi
  • Research Location

    Italy
  • Lead Research Institution

    University of Tuscia and CNR
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Molecular Dynamics investigation of the interaction between ACE2 and the spike glycoprotein of SARS-CoV-2, in comparison with its predecessors from bat and pangolin takes a completely different approach. It is led by Prof. Giovanni Chillemi from University of Tuscia and CNR in Italy. He and his team plan a time-travel molecular dynamics investigation: interaction between a receptor of human cells - ACE2 and the spike glycoprotein of SARS-CoV-2 - and its predecessors in bats and pangolins. The goal of this project is to compare structural and dynamic properties of the spike glycoprotein in SARS-CoV-2, bat-SL-CoVs, BetaCoV_pangolin and the Italian variant hCoV-19/INMI1-isl/2020 by means of micro-second molecular dynamic simulations. The idea is to shed light on some specific features the virus gained that have facilitated its successful spread as compared to its predecessors. These results are preparatory for the identification of inhibitors that may reduce substantially the infectiousness of SARS-CoV-2. High computational power is necessary for such research: only spike glycoprotein trimer already has 600 000 atoms, ACE2 in complex with one spike trimer has 1.2 million atoms and with two 2.1 million atoms. PRACE awarded the team with 3 000 000 core hours on Marconi100, hosted by CINECA, Italy.